Glucose Health, Inc. --
Fiscal 2020 Annual Report &
Q1 2021 Revenue
Guidance
BENTONVILLE, AR
-- March
31,
2021 -- InvestorsHub
NewsWire -- Glucose Health, Inc. (OTC:
GLUC) ("Company")
is
pleased to highlight
key
financial metrics detailed in
its
Fiscal 2020 Annual Report posted today at
OTCMarkets.com, and
additionally,
pleased
to provide
guidance
for revenue expected
for the
1st
quarter
of 2021.
- Fiscal 2020
Revenue
of
$480,713
vs.
$291,213
for Fiscal
2019
= a 65%
Increase
- Fiscal 2020 Gross
Profit of $173,545
vs.
$82,679
for Fiscal
2019
= a 110%
Increase
- Fiscal 2020 Total
Liabilities of $303,527 vs.
$380,652 for Fiscal
2019
= a 20%
Decrease
- Fiscal
2021
Q1
Revenue of
$207,000
vs. $82,613
for
Fiscal
2020
Q1
Revenue = a
150%
Increase
On
February 3, 2020, Glucose Health,
Inc. issued
by press
release, the following five
strategic goals to be achieved
for
fiscal 2020:
- Amazon Growth. Amazon
is the fasting growing distribution channel and key to achieving
GLUCODOWN® sales revenue targets in 2020.
- More Pharmacy
Retailer Partnerships. We are in active pursuit of shelf space at
national pharmacy retailers to further increase distribution of
GLUCODOWN®.
- Direct Response
Sales. Establish a direct response sales channel with toll-free
number plus expanded TV advertising on Hallmark, Game Show
Network, National Geographic
and new for 2020, Fox News Channel
- Additional Line
Extensions. Introduce differentiated container sizes for all four
flavors of GLUCODOWN® tailored to individual distribution channels;
smaller containers for budget retailers; larger containers for
full-service pharmacy retailers.
- Increase Profit
Margins by 50%. Increase profit margin by 50% through improved
production methods and cost-control and selected retailer product
price increases."
The
Company's success in achieving
all
five Strategic
Goals
during
fiscal 2020 was exemplary.
Goal #1 – Amazon
Growth: On May 13, 2020,
fully seven months prior to the end of fiscal 2020, the Company
provided revenue guidance by press release, for the first time,
indicating that sales at Walmart and Amazon were on a trajectory to
potentially reach $500,000 by fiscal year end. With total revenues
of $480,713 achieved in fiscal 2020, such guidance, when
periodically issued by the Company, can be relied upon with
confidence, by all shareholders and interested
investors.
Revenue
for the first quarter of fiscal 2021 is expected to be greater than
$207,000; a 150% increase or more than double revenues achieved in
the first quarter of fiscal 2020.
The
GLUCODOWN® brand is
less than
three years old. The
GLUCODOWN® trademark was
first
registered with the
United States Patent and Trademark Office (USPTO) on September 25,
2018. The Company applied for and received Amazon's
designation
of
GLUCODOWN® as
a
registered
brand in the
Amazon
Brand Registry and opened its
Amazon store (www.amazon.com/glucodown) with first product
sales at the
close of
fiscal 2018.
In
the
last 2 fiscal
years,
2019 and 2020, the GLUCODOWN®
brand has experienced
continuous and
accelerating sales growth at Amazon – unequivocal evidence
of the brand's popularity
within its target
consumer market. GLUCODOWN® is
unique.
It's a delicious
tasting
beverage…that
additionally
provides beneficial
and often
measurable physiological impacts
for many millions of potential
consumers.
Goal #2 – More
Retailers: In
fiscal
2020, the Company secured placement of all four flavors
of GLUCODOWN®
iced tea
beverages with its
second, national,
pharmacy
retailer chain, in addition to
Walmart, CVS
Pharmacies. Prior to final
placement on CVS Pharmacy shelves, GLUCODOWN® was submitted to NSF
International by requirement of CVS
Pharmacies, for rigorous
testing, including
the
validity of all label claims. GLUCODOWN® passed all tests
in
its
first
testing
protocol
–
testament to the outstanding
quality
of the GLUCODOWN®
brand
and the
world-class ingredient manufacturers and processors within the
Glucose Health, Inc. supply chain.
Goal #3 – More Brand
Awareness: In
fiscal
2020, the
Company expanded its advertising well
beyond
Hallmark,
Game Show Network, National Geographic
and Fox News Channel, to
also
include
many
additional popular cable
channels such as Great American Country. The
Company
also
pushed
shorter versions of its TV commercial through regular Facebook
advertising for the first
time, with excellent
viewership. In Q1 fiscal
2021, the
Company advertised on CNBC's popular Shark Tank program –
with a robust
GLUCODOWN®
sales jump –
indicating
the
wide
demographic reach of
the
GLUCODOWN® brand.
Goal # 4 – More
Products: During
the first
quarter of fiscal 2021, the Company launched new variety and double
packs of its existing GLUCODOWN® iced
tea beverages
at
Amazon, in a test of consumer demand for such offerings. The
response of customers to these new purchasing options has been
extraordinary. All initial supply sold-out within weeks. More
supply has reached Amazon and today, all possible variations of the
four GLUCODOWN® iced tea flavors are available for purchase at
Amazon, on a permanent basis.
New GLUCODOWN® Enhanced Water Beverages
The
Company did not succeed in its goal of launching its new line up
of GLUCODOWN®
enhanced
water beverages by the end of the fiscal year 2020.
The
Company is aware that expectations are very high for this new
product line up given the high quality of its current line-up of
GLUCODOWN® iced tea beverages.
From
September
2020 to the present, the Company has
conducted
four separate pilot-scale manufacturing trials of its new
enhanced
water beverages and multiple
flavor and processing
refinements
have
taken
place.
As of
today, the Company has perfected Watermelon, Cherry, Peach-Mango
and Strawberry-Banana for commercial
production. The first purchase orders for raw ingredients, in
quantities for full
commercial launch
of
GLUCODOWN® enhanced
water beverages. were issued last
week, with an
availability date on Amazon expected to be announced before the end
of the 2nd
quarter.
Goal #5 – Increasing
Profit: In
fiscal
2020, despite many increased
logistics and raw materials costs
and a
number of supplier
disruptions,
some
related
to the pandemic, Glucose Health,
Inc. more than
doubled its
Gross
Profit.
Additionally,
the Company
also
increased
its overall gross
profit
margin to 36% for
Fiscal 2020 vs. 28% for Fiscal
2019.
About Glucose Health, Inc. (OTC: GLUC)
Introduced
in
the third
quarter of 2018
and
manufactured by Glucose Health, Inc., the
GLUCODOWN®
brand
has
come
to define an entirely
new and distinct nutritional
supplement
category – functional,
diabetic
friendly,
beverages. By specializing in
producing delicious and
efficacious beverages
nutritionally appropriate1
for the
nation's 100+ million2
pre and
Type-2 diabetics, GLUCODOWN® is uniquely and strongly positioned
among all up & coming beverage companies in America.
Glucose
Health, Inc. is a publicly traded company with the ticker symbol
OTC: GLUC.
For more GLUC news
visit www.glucosehealthinc.com
Like us on Facebook at www.facebook.com/glucodown
1
For
citations visit www.glucodown.com/clinical-data
2
National Diabetes Statistics Review, 2020;
Centers for Disease Control and Prevention, Department of Health
and Human Services
This
news
release contains forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and
while
Glucose
Health, Inc. is not subject to the 1934 Securities and Exchange
Act, contains
forward-looking statements within the meaning Section 21E of the
Securities and Exchange Act of 1934, as amended. Statements that
are not a description of historical facts constitute
forward-looking statements and may often, but not always, be
identified by the use of such words as "expects," "anticipates,"
"intends," "estimates," "plans," "potential, "possible," "probable,
"believes," "seeks," "may, "will, "should," "could" or the negative
of such terms or other similar expressions. Actual results may
differ materially from those set forth in this release due to the
risks and uncertainties inherent in the Company's business. Readers
are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. All
forward-looking statements are qualified in their entirety by this
cautionary statement and the Company undertakes no obligation to
revise or update this release to reflect events or circumstances
after the date hereof.
Contact:
Murray
Fleming
Glucose Health,
Inc.
info@glucosehealthinc.com
(479)
802-3827
